Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients-Reference-Cited by-同舟云学术

Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients

Published:2019-11-12 Issue:1 Volume:40 Page:32-44
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Ing Lorenzini Kuntheavy¹^ORCID,Girardin François¹^ORCID

Affiliation:

1. Division of Clinical Pharmacology and Toxicology University Hospitals of Geneva Geneva Switzerland

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14283

Reference108 articles.

1. World Health Organization.Global Hepatits Report 2017.2017.https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf;jsessionxml:id=4E6AD00C9627B83CF31560A03EC0117E?sequence=1.Accessed June 17 2019.

2. Global Elimination of Chronic Hepatitis

3. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

4. Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection

5. HCV point‐of‐care screening programme and treatment options for people who use drugs in a metropolitan area of Southern Italy

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021;Harm Reduction Journal;2023-10-01

2. Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations;Infectious Diseases and Therapy;2023-07-20

3. Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study;PLOS ONE;2023-02-02

4. Efficacy of a comprehensive strategy for the detection and treatment of hepatitis C infection in a population attending addiction centers;Frontiers in Public Health;2023-02-02

5. Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan;Hepatology International;2023-01-26